Compare ETN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETN | ABT |
|---|---|---|
| Founded | 1916 | 1888 |
| Country | Ireland | United States |
| Employees | 101000 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.3B | 152.9B |
| IPO Year | 2012 | 2006 |
| Metric | ETN | ABT |
|---|---|---|
| Price | $403.36 | $94.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 20 |
| Target Price | ★ $401.95 | $130.90 |
| AVG Volume (30 Days) | 2.3M | ★ 9.6M |
| Earning Date | 05-05-2026 | 04-16-2026 |
| Dividend Yield | 1.07% | ★ 2.76% |
| EPS Growth | ★ 10.00 | N/A |
| EPS | ★ 2.22 | 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $12.72 | $10.75 |
| Revenue Next Year | $9.54 | $8.10 |
| P/E Ratio | $188.85 | ★ $152.64 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $311.92 | $81.97 |
| 52 Week High | $436.74 | $137.49 |
| Indicator | ETN | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 61.79 |
| Support Level | $355.03 | $86.02 |
| Resistance Level | $408.45 | $112.81 |
| Average True Range (ATR) | 14.19 | 2.26 |
| MACD | 0.35 | 0.59 |
| Stochastic Oscillator | 42.19 | 77.89 |
Founded in 1911 by Joseph Eaton, the eponymous company began by selling truck axles in New Jersey. Eaton has since become an industrial powerhouse largely through acquisitions in various end markets. Eaton's portfolio can broadly be divided into two parts: its electrical and industrial businesses. Its electrical portfolio (representing around 70% of company revenue) sells components within data centers, utilities, and commercial and residential buildings, while its industrial business (30% of revenue) sells components within commercial and passenger vehicles and aircraft. Eaton receives favorable tax treatment as a domiciliary of Ireland, but it generates over half of its revenue within the US.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.